Literature DB >> 36199540

Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Changlong Li1, Zhen Guan2, Yi Zhao1, Tingting Sun1, Zhongwu Li3, Weihu Wang4, Zhexuan Li5, Lin Wang1, Aiwen Wu1.   

Abstract

Objective: The accurate prediction of tumor response to neoadjuvant chemoradiotherapy (nCRT) remains challenging. Few studies have investigated pathologic complete response (ypCR) prediction in patients with residual flat mucosal lesions after treatment. This study aimed to identify variables for predicting ypCR in patients with residual flat mucosal lesions after nCRT for locally advanced rectal cancer (LARC).
Methods: Data of patients with residual flat mucosal lesions after nCRT who underwent radical resection between 2009 and 2015 were retrospectively collected from the LARC database at Peking University Cancer Hospital. Univariate and multivariate analyses of the association between clinicopathological factors and ypCR were performed, and a nomogram was constructed by incorporating the significant predictors.
Results: Of the 246 patients with residual flat mucosal lesions included in the final analysis, 56 (22.8%) had ypCR. Univariate and multivariate analyses showed that pretreatment cT stage (pre-cT) ≤T2 (P=0.016), magnetic resonance tumor regression grade (MR-TRG) 1-3 (P=0.001) and residual mucosal lesion depth =0 mm (P<0.001) were associated with a higher rate of ypCR. A nomogram was developed with a concordance index (C-index) of 0.759 and the calibration curve showed that the nomogram model had good predictive consistency. The follow-up time ranged from 3.0 to 113.3 months, with a median follow-up time of 63.77 months. The multivariate Cox regression model showed that the four variables in the nomogram model were not risk factors for disease-free survival (DFS) or overall survival (OS). Conclusions: Completely flat mucosa, early cT stage and good MR-TRG were predictive factors for ypCR instead of DFS or OS in patients with LARC with residual flat mucosal lesions after nCRT. Endoscopic mucosal re-evaluation before surgery is important, as it may contribute to decision-making and facilitate nonoperative management or organ preservation. © Chinese Journal of Cancer Research. All rights reserved.

Entities:  

Keywords:  Rectal cancer; flat mucosal lesions; pathologic complete response; preoperative chemoradiotherapy; tumor regression grade

Year:  2022        PMID: 36199540      PMCID: PMC9468014          DOI: 10.21147/j.issn.1000-9604.2022.04.06

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   4.026


  40 in total

Review 1.  Preoperative staging of rectal cancer.

Authors:  Neil Smith; Gina Brown
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

2.  Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.

Authors:  Lin Wang; Zi-Yu Li; Zhong-Wu Li; Yong-Heng Li; Ying-Shi Sun; Jia-Fu Ji; Jin Gu; Yong Cai
Journal:  Dis Colon Rectum       Date:  2015-02       Impact factor: 4.585

3.  Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Authors:  In Ja Park; Y Nancy You; Atin Agarwal; John M Skibber; Miguel A Rodriguez-Bigas; Cathy Eng; Barry W Feig; Prajnan Das; Sunil Krishnan; Christopher H Crane; Chung-Yuan Hu; George J Chang
Journal:  J Clin Oncol       Date:  2012-04-09       Impact factor: 44.544

4.  Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy.

Authors:  Jemma Bhoday; Fraser Smith; Muhammed R Siddiqui; Svetlana Balyasnikova; Robert I Swift; Rodrigo Perez; Angelita Habr-Gama; Gina Brown
Journal:  Dis Colon Rectum       Date:  2016-10       Impact factor: 4.585

Review 5.  Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.

Authors:  Mikael Soucisse; Joseph C Kong; Michael Michael; Jeanne Tie; Samuel Y Ngan; Trevor Leong; Jacob McCormick; Satish K Warrier; Alexander G Heriot
Journal:  Ann Surg Oncol       Date:  2021-04-23       Impact factor: 5.344

6.  Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.

Authors:  Francesco Sclafani; Gina Brown; David Cunningham; Andrew Wotherspoon; Larissa Sena Teixeira Mendes; Svetlana Balyasnikova; Jessica Evans; Clare Peckitt; Ruwaida Begum; Diana Tait; Josep Tabernero; Bengt Glimelius; Susana Roselló; Janet Thomas; Jacqui Oates; Ian Chau
Journal:  Br J Cancer       Date:  2017-09-21       Impact factor: 7.640

7.  Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center.

Authors:  Meng-Lan Zhai; Fang-Yuan Zhang; Jin-Ru Yang; Sheng Zhang; Lei Zhao; Zhen-Yu Lin; Jing Wang; Dan-Dan Yu; Tao Zhang
Journal:  Radiat Oncol       Date:  2022-06-20       Impact factor: 4.309

8.  Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.

Authors:  J Joshua Smith; Oliver S Chow; Marc J Gollub; Garrett M Nash; Larissa K Temple; Martin R Weiser; José G Guillem; Philip B Paty; Karin Avila; Julio Garcia-Aguilar
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430

9.  Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer.

Authors:  Jianhong Peng; Junzhong Lin; Miaozhen Qiu; Xiaojun Wu; Zhenhai Lu; Gong Chen; Liren Li; Peirong Ding; Yuanhong Gao; Zhifan Zeng; Huizhong Zhang; Desen Wan; Zhizhong Pan
Journal:  Clinics (Sao Paulo)       Date:  2016-08       Impact factor: 2.365

10.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer.

Authors:  Marco Rengo; Simona Picchia; Simona Marzi; Davide Bellini; Damiano Caruso; Mauro Caterino; Maria Ciolina; Domenico De Santis; Daniela Musio; Vincenzo Tombolini; Andrea Laghi
Journal:  Oncotarget       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.